Mefloquine

"Mefloquine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A phospholipid-interacting antimalarial drug (ANTIMALARIALS). It is very effective against PLASMODIUM FALCIPARUM with very few side effects.

Descriptor ID	D015767
MeSH Number(s)	D03.633.100.810.410
Concept/Terms	Mefloquine Mefloquine Mephloquine WR-177,602 WR-177,602 WR 177,602 WR177,602 Ro-21-5998-001 Ro-21-5998-001 Ro 21 5998 001 Ro215998001 WR-142,490 WR-142,490 WR 142,490 WR142,490 Lariam Lariam Mefloquine Hydrochloride Mefloquine Hydrochloride

Below are MeSH descriptors whose meaning is more general than "Mefloquine".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, Fused-Ring [D03.633]
Heterocyclic Compounds, 2-Ring [D03.633.100]
Quinolines [D03.633.100.810]
Mefloquine [D03.633.100.810.410]

Below are MeSH descriptors whose meaning is related to "Mefloquine".

Below are MeSH descriptors whose meaning is more specific than "Mefloquine".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Mefloquine" by people in this website by year, and whether "Mefloquine" was a major or minor topic of these publications.

Bar chart showing 4 publications over 4 distinct years, with a maximum of 1 publications in 2011 and 2012 and 2017 and 2025

To see the data from this visualization as text, click here.

Year	Minor Topic	Total
2011	1	1
2012	1	1
2017	1	1
2025	1	1

Below are the most recent publications written about "Mefloquine" by people in Profiles.

Okitwi M, Orena S, Tumwebaze PK, Katairo T, Taremwa Y, Byaruhanga O, Tukwasibwe S, Nsobya SL, Legac J, Bailey JA, Cooper RA, Conrad MD, Rosenthal PJ. Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024. Nat Commun. 2025 Aug 09; 16(1):7353.

View in: PubMed
Parobek CM, Parr JB, Brazeau NF, Lon C, Chaorattanakawee S, Gosi P, Barnett EJ, Norris LD, Meshnick SR, Spring MD, Lanteri CA, Bailey JA, Saunders DL, Lin JT, Juliano JJ. Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia. Genome Biol Evol. 2017 06 01; 9(6):1673-1686.

View in: PubMed
Sukhai MA, Prabha S, Hurren R, Rutledge AC, Lee AY, Sriskanthadevan S, Sun H, Wang X, Skrtic M, Seneviratne A, Cusimano M, Jhas B, Gronda M, MacLean N, Cho EE, Spagnuolo PA, Sharmeen S, Gebbia M, Urbanus M, Eppert K, Dissanayake D, Jonet A, Dassonville-Klimpt A, Li X, Datti A, Ohashi PS, Wrana J, Rogers I, Sonnet P, Ellis WY, Corey SJ, Eaves C, Minden MD, Wang JC, Dick JE, Nislow C, Giaever G, Schimmer AD. Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors. J Clin Invest. 2013 Jan; 123(1):315-28.

View in: PubMed
Van Tyne D, Park DJ, Schaffner SF, Neafsey DE, Angelino E, Cortese JF, Barnes KG, Rosen DM, Lukens AK, Daniels RF, Milner DA, Johnson CA, Shlyakhter I, Grossman SR, Becker JS, Yamins D, Karlsson EK, Ndiaye D, Sarr O, Mboup S, Happi C, Furlotte NA, Eskin E, Kang HM, Hartl DL, Birren BW, Wiegand RC, Lander ES, Wirth DF, Volkman SK, Sabeti PC. Identification and functional validation of the novel antimalarial resistance locus PF10_0355 in Plasmodium falciparum. PLoS Genet. 2011 Apr; 7(4):e1001383.

View in: PubMed

People

Explore

Similar Concepts

Top Journals